Homocysteine-induced enhanced expression of tissue factor in human vascular smooth muscle cells

Abstract

The homocysteine (Hcy)-induced tissue factor (TF) expression in human vascular smooth muscle cells (VSMCs) and the effect of Hcy on the activity of nuclear factor-kappaB (NF-κB) and the expression of inducible nitric oxide synthase (iNOS) were investigated. Human umbilical artery VSMCs were cultured by tissue explanting method, identified by α-actin immunohistochemistry, and incubated with different concentrations of Hcy/PTDC (NF-κB inhibitor). Semi-quantitative RT-PCR was performed to detect the expression of TF mRNA in VSMCs. Flow cytometry was used to assay the expression of TF protein on the surface of VSMCs and the expression of iNOS in VSMCs. Western blot was carried out to detect the expression of NF-κB protein in nuclei. The results showed that Hcy could induce VSMCs expressing TF mRNA significantly after the VSMCs were incubated with Hcy at concentrations of 10, 100, 500 μmol/L respectively. There was low expression level of TF protein on the surface of the resting VSMCs and Hcy could also induce VSMCs expressing TF protein on the cell surface in different concentrations. Additionally, Hcy could rapidly induce the activation of NF-κB and this effect could be significantly inhibited by PDTC. Hcy alone could not induce the expression of iNOS in VSMCs. It was concluded that Hcy could significantly induce the expression of TF in VSMCs and enhance the activation of NF-KB, subsequently mediate TF gene expression and protein synthesis. NF-κB-mediated expression of TF in VSMCs might be the important mechanism of atherosclerosis and thrombosis induced by Hcy.

Keywords

homocysteine / vascular smooth muscle cell / tissue factor / nuclear factor kappaB / inducible nitric oxide synthase

References

[1] MarmurJ. D., ThiruvikramanS. V., FyfeB. S., et al.. Identification of active tissue factor in human coronary atheroma. Circulation, 1996, 94: 1226-1232

[2] MorenoP. R., BernardiV. H., Lopex-CuellarJ., et al.. Macrophages, smooth muscle cells and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation, 1996, 94: 3090-3097

[3] HatakeyamaK., AsadaY., MarutsukaK., et al.. Localization and activity of tissue factor in human aortic atherosclerotic lesions. Atherosclerosis, 1997, 133(2): 213-219

[4] FryerR. H., WilsonB. D., GublerD. B.. Homocysteine, risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb, 1993, 13: 1327-1333

[5] TianX. M., LiJ.. Cell culture of human vascular smooth muscle cells. Prog Anat Sci (Chinese), 1995, 5: 85-86

[6] SchreiberE., MatthiasP., MullerM. M., et al.. Rapid detection of octamer binding proteins with “mini-extracts”, prepared from a small number of cells. Nucleic Acids Res, 1989, 17: 6419

[7] HofmanM. A., LallaE., LuY., et al.. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest, 2001, 107: 675-683

[8] BozkurtA., ToyaksiH., AcarturkE., et al.. The effects of hyperhomocyteinemia on the presence, extent, and severity of coronary artery disease. Jpn Heart J, 2003, 44(3): 357-368

[9] SoysalD., SavaşS., SusamI., et al.. The association of plasma homocysteine, coronary risk factors and serum nitrite in patients with coronary artery disease, vascular syndrome x and healthy subjects. Anadolu Kardiyol Derg, 2003, 3(1): 26-34

[10] Faria-NetoJ. R., ChagasA. C., BydlowskiS. P., et al.. Hyperhomocystinemia in patients with coronary artery disease. Braz J Med Biol Res, 2006, 39(4): 455-463

[11] FanapourP. C., YugB., KocharM. S.. Hyperhomocysteinemia: an additional cardiovascular risk factor. WMJ, 1999, 98(8): 51-54

[12] PollmanM. J., YamadaT., HoriuchiM., et al.. Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin. Cir Res, 1996, 79: 748-756

[13] OrtegoM., BustosC., Hernandez-PresaM. A., et al.. Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis, 1999, 147: 253-261

[14] WilsonS. H., CapliceN. M., SimariR. D., et al.. Activated nuclear factor-κB is present in the coronary vasculature in experimental hypercholesterolemia. Atherosclerosis, 2000, 148: 23-30

[15] YanZ. Q., SirsjöA., Bochaton-PillatM. L., et al.. Augmented expression of inducible NO synthase in vascular smooth muscle cells during aging is associated with enhanced NF-kappaB activation. Arterioscler Thromb Vasc Biol, 1999, 19(12): 2854-2862

[16] BrandK., PageS., RoglerG., et al.. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest, 1996, 97: 1715-1722

[17] KatsuyamaK., ShichiriM., MarumoF., et al.. Role of nuclear factor-kappaB activation in cytokine-and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells. Endocrinology, 1998, 139(11): 4506-4512

[18] WelchG. N., UpchurchG. R.Jr, FarivarR. S., et al.. Homocysteine-induced nitric oxide production in vascular smooth muscle cells by NF-κB-dependent transcriptional activation of Nos2. Proc Assoc Am Physicians, 1998, 110: 22-31

[19] IkedaU., IkedaM., MinotaS., et al.. Homocysteine increases nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells. Circulation, 1999, 99(9): 1230-1235

[20] KibbeM. R., JohnnidesC., GleixnerS., et al.. Regulation of tissue factor expression in smooth muscle cells with nitric oxide. J Vasc Surg, 2003, 37: 650-659